Fondaparinux Compared with Enoxaparin for the Prevention of Venous Thromboembolism after Elective Major Knee Surgery
Authors:
- Kenneth A. BauerKBKenneth A. Bauer
- Bengt I. ErikssonBEBengt I. Eriksson
- Michael R. LassenMLMichael R. Lassen
- Alexander G.G. TurpieATAlexander G.G. Turpie
Top Cited Papers
Open Access
- 1 November 2001
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 345 (18) , 1305-1310
Abstract
Despite thromboprophylaxis, major knee surgery carries a high risk of venous thromboembolism. Fondaparinux, the first of a new class of synthetic antithrombotic agents, may reduce this risk.Keywords
This publication has 15 references indexed in Scilit:
- Fondaparinux Compared with Enoxaparin for the Prevention of Venous Thromboembolism after Hip-Fracture SurgeryNew England Journal of Medicine, 2001
- A Synthetic Pentasaccharide for the Prevention of Deep-Vein Thrombosis after Total Hip ReplacementNew England Journal of Medicine, 2001
- Cannabis Arteritis RevisitedAngiology, 2001
- Prevention of Venous ThromboembolismChest, 2001
- Low-Molecular-Weight Heparin Prophylaxis Using Dalteparin in Close Proximity to Surgery vs Warfarin in Hip Arthroplasty PatientsArchives of internal medicine (1960), 2000
- Prevention of deep-vein thrombosis after total hip replacement: direct thrombin inhibition with recombinant hirudin, CGP 39393The Lancet, 1996
- The Unique Antithrombin III Binding Domain of Heparin: A Lead to New Synthetic AntithromboticsAngewandte Chemie International Edition, 1993
- Value of the ventilation/perfusion scan in acute pulmonary embolism. Results of the prospective investigation of pulmonary embolism diagnosis (PIOPED). The PIOPED InvestigatorsJAMA, 1990
- The inhibition of the generation of thrombin and the antithrombotic effect of a pentasaccharide with sole anti-factor Xa activityThrombosis Research, 1988
- Roentgen Diagnosis of Venous Thrombosis in the LegArchives of Surgery, 1972